ストックスクリーナーアプリを入手
10.80
6.44%
0.63
前日終値:
$10.17
開ける：
$10.34
24時間の取引高:
41,355
Relative Volume:
0.12
時価総額：
$575.67M
収益：
-
当期純損益:
$-83.74M
株価収益率:
-6.7081
EPS:
-1.61
ネットキャッシュフロー:
$-64.98M
1週間 パフォーマンス:
+18.96%
1か月 パフォーマンス:
+8.25%
6か月 パフォーマンス:
-31.18%
1年 パフォーマンス:
-45.33%
1日の値動き範囲:
$10.34
$10.95
1週間の範囲:
$9.02
$10.95
52週間の値動き範囲:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
TYRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.82 | 491.90M | 0 | -83.74M | -64.98M | -1.61 |
|
ONC
Beone Medicines Ltd Adr
|
256.89 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
448.00 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2213 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.35 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
498.02 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-21 | 再開されました | Piper Sandler | Overweight |
| 2025-01-07 | 開始されました | UBS | Buy |
| 2024-10-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-08-15 | 開始されました | Piper Sandler | Overweight |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-06-30 | 開始されました | Wedbush | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-03-08 | アップグレード | Jefferies | Hold → Buy |
| 2021-11-08 | ダウングレード | Jefferies | Buy → Hold |
| 2021-10-11 | 開始されました | BofA Securities | Buy |
| 2021-10-11 | 開始されました | Cowen | Outperform |
| 2021-10-11 | 開始されました | Jefferies | Buy |
すべてを表示
Tyra Biosciences Inc (TYRA) 最新ニュース
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of “Buy” from Analysts - Defense World
Trend Tracker for (TYRA) - news.stocktradersdaily.com
BNP Paribas Financial Markets Purchases New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Deutsche Bank AG Acquires 6,466 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Millennium Management LLC Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Bioscience Holds 2025 Annual Stockholders Meeting - TipRanks
TYRA Stock: Upcoming Oppenheimer Meeting Announcement | TYRA Sto - GuruFocus
Trading (TYRA) With Integrated Risk Controls - news.stocktradersdaily.com
Northern Trust Corp Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Piper Sandler Begins Coverage on Tyra Biosciences (NASDAQ:TYRA) - Defense World
HC Wainwright Forecasts Higher Earnings for Tyra Biosciences - Defense World
What is HC Wainwright’s Forecast for TYRA FY2026 Earnings? - Defense World
Tyra Biosciences (TYRA) Receives Overweight Rating from Piper Sandler | TYRA Stock News - GuruFocus
Tyra Biosciences (TYRA): Analyst Bullish with Overweight Rating and $33 Target | TYRA Stock News - GuruFocus
Dimensional Fund Advisors LP Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
(TYRA) Trading Report - news.stocktradersdaily.com
Transcript : Tyra Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 05 - marketscreener.com
Tyra Biosciences Reports Increased R&D Investment in Q1 2025 - TipRanks
Tyra Biosciences to Participate at Upcoming Investor Conferences - Citizen Tribune
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Rating of “Buy” by Brokerages - Defense World
Wells Fargo & Company MN Grows Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
What Will Tyra Biosciences Inc (NASDAQ: TYRA) Be Like In 2025 - Stocksregister
Tyra Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
One Tyra Biosciences Insider Raised Stake By 284% In Previous Year - Yahoo Finance
Barclays PLC Grows Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Kaskela Law LLC Announces Investigation of Tyra Biosciences, Inc. (NASDAQ:TYRA) and Encourages Investors to Contact the Firm for Additional Information - ACCESS Newswire
Tyra Biosciences (TYRA) Secures Financial Stability for Oncology Advancements | TYRA Stock News - GuruFocus
Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights - Kilgore News Herald
Analytical Lens: Exploring Tyra Biosciences Inc (TYRA)’s Financial Story Through Ratios - DWinneX
54,783 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Acquired by Raymond James Financial Inc. - Defense World
29,100 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Renaissance Technologies LLC - Defense World
Tyra Biosciences Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Tyra Biosciences (TYRA) to Release Earnings on Thursday - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by JPMorgan Chase & Co. - Defense World
Russell Investments Group Ltd. Acquires 10,447 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Geode Capital Management LLC Has $7.20 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences Inc [TYRA] Records 50-Day SMA of $10.39 - knoxdaily.com
Should investors be concerned about Tyra Biosciences Inc (TYRA)? - uspostnews.com
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.83 Average PT from Brokerages - Defense World
(TYRA) Investment Analysis and Advice - news.stocktradersdaily.com
Vanguard Group Inc. Sells 37,643 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Wellington Management Group LLP Has $1.32 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
American Century Companies Inc. Sells 20,857 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Why WaFd Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga
KLP Kapitalforvaltning AS Buys New Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - ACCESS Newswire
Advanced Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com
Raymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
HC Wainwright Predicts Reduced Earnings for Tyra Biosciences - Defense World
Tyra Biosciences Inc (TYRA) 財務データ
収益
当期純利益
現金流量
EPS
1.30%
3.35%
大文字化:
|
ボリューム (24 時間):